beluuga.ai

Overview

Precision Instruments

JMS CO.,LTD.

JMS Co., Ltd. is a Japanese medical device and pharmaceutical manufacturer focused on developing and commercializing products for clinical and home healthcare settings. The company offers solutions spanning oral nutrition support, regenerative medicine, infusion/drug delivery safety, and home medical care. JMS markets its products domestically through its core operations and an equity-method affiliate (J.O. Pharma), and internationally across Singapore, China, the Philippines, Germany, the United States, South Korea, Thailand, and other regions through dedicated local subsidiaries.

Market Cap

¥10.8B

US$68.8M

¥23.6B

US$151M

Stock¥440▼-2.00%

US$1 = ¥156.80 (2026-10-23)

LTM EV/EBITDA

5.5

LTM EV/EBIT

54.1

LTM PER

LTM PBR

0.3

Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-22.2%pt

Oct 24, 25 – Oct 23, 26StockTOPIX

MC → EV Bridge

AI Briefing

Generating insights…

Performance & Balance

Revenue 5Y (¥B)

EBITDA 5Y (¥B)

Net Income 5Y (¥B)

Capital Structure

60%

40%

EquityD/E 0.66xDebt

Liquidity vs Debt 5Y (¥B)▼ Net Debt

CashInv. Sec.Debt

Shareholders

Top 10 hold 48.2%

as of 2026-03-31 · Source: Annual Securities Report

KANEKA CORPORATION

10.35%

The Master Trust Bank of Japan, Ltd. (Trust Account)

8.36%

Tsuchiya Memorial Medical Promotion Foundation (General Incorporated Foundation)

7.74%

Saeko TSUCHIYA

4.10%

Senjukai Social Welfare Corporation

4.07%

The Hiroshima Bank, Ltd.

3.65%

JMS Kyoei-kai

3.07%

The Dai-ichi Life Insurance Company, Limited

2.63%

Oshita Sangyo Co., Ltd.

2.32%

Sense LLC

1.93%

Management

11 officers

Hiroaki OKUKUBO

Director, Chairman of the Board

Apr 1978 Joined the Company Jul 2000 Head of President's Office, the Company Jun 2001 Executive Officer, the Company Jun 2005 Director, Deputy Head of Corporate Management Division, the Company Jun 2007 Managing Director, Head of Corporate Management Division, the Company Jun 2011 Representative Director, President, the Company Jun 2023 Representative Director, Chairman, the Company Jun 2024 Director, Chairman of the Board, the Company (current)

1955-10-23

Ryuji KATSURA

Representative Director, President

Apr 1988 Joined the Company Jul 2010 General Manager, Corporate Planning Department, the Company Jul 2011 Executive Officer, the Company Jun 2013 Director in charge of Corporate Planning, the Company Apr 2017 Head of Corporate Planning Division, the Company Jul 2019 Head of Global Marketing Division, the Company Apr 2021 Head of Corporate Division, the Company Jun 2021 Managing Director, the Company Jun 2023 Representative Director, President, the Company (current)

1963-07-30

Yasuhiro AWANE

Director, Executive Vice President, Head of Sales Division

Apr 1984 Joined the Company Apr 2010 Head of Sales Promotion Division, the Company Jun 2011 Director, General Manager, Sales Division, the Company Jun 2013 Director in charge of Sales, the Company Jun 2015 Managing Director, the Company Apr 2017 General Manager, Surgical & Therapy Business Unit, Head of Sales Division, the Company (current) Jun 2021 Senior Managing Director, the Company Jun 2023 Director, Executive Vice President, the Company (current) Jul 2023 Head of Management Strategy Office, the Company

1961-04-27

Shogo YANAGIDA

Director, Head of Production Division

Apr 1986 Joined the Company Nov 2011 Head of Technology Department, Izumo Plant, the Company Jul 2013 Executive Officer, Head of Miyoshi Plant, the Company Jun 2017 Director, Deputy Head of Production Division, the Company (current) Jun 2019 Head of Production Division, the Company (current) Apr 2020 General Manager, Blood Management & Cell Therapy Business Unit, the Company Jun 2023 Head of Izumo Plant, the Company

1963-01-05

Toru SAKODA

Director, Head of Global Marketing Division

Apr 1989 Joined the Company Apr 2012 Head of Third Research Laboratory, Central Research Institute, the Company Jul 2017 Executive Officer, General Manager, Therapeutic Device Promotion Department, Surgical & Therapy Business Unit, the Company Jul 2019 Representative Director, President, J.M.S. Singapore Pte. Ltd. Jun 2023 Director, Head of Global Marketing Division, the Company (current)

1966-12-20

Raita UEMATSU

Director, Head of R&D Division

Oct 2001 Joined the Company Jun 2018 Deputy General Manager, Izumo Plant, the Company Jul 2019 Executive Officer, Head of Izumo Plant, the Company Jun 2023 Director, Head of R&D Division, the Company (current)

1967-03-02

Kazuaki IKEMURA

Director

Apr 1983 Registered as attorney-at-law (Hiroshima Bar Association) Jun 1983 Joined Tomikawa Law Office Aug 1991 Opened Hiroshima Chuo Law Office (current) Jun 2011 Audit & Supervisory Board Member, the Company Jun 2015 Director, the Company (current) Jun 2020 Outside Audit & Supervisory Board Member, Fukutome Ham Co., Ltd. Jun 2023 Outside Director, Audit and Supervisory Committee Member, Fukutome Ham Co., Ltd. (current)

1953-02-26

Shozo ISHIZAKA

Director

Apr 1985 Joined Kanegafuchi Chemical Industry Co., Ltd. (now Kaneka Corporation) Jun 2010 Director, Kaneka Medix Corporation; Group Leader, Vascular Management Group, Sales Division; Head of Asia Office Apr 2017 Senior Managing Director, Kaneka Corporation Apr 2018 Representative Director, President, Kaneka Corporation Jun 2019 Director, the Company (current) Apr 2023 Executive Officer, Kaneka Corporation (current)

1962-05-11

Yoshio KONDO

Director, Audit and Supervisory Committee Member (Full-time)

Apr 1980 Joined the Company Jul 2005 General Manager, Overseas Business Division, the Company Jul 2011 Executive Officer, Representative Director, President, J.M.S. Singapore Pte. Ltd. Jun 2015 General Manager, Finance Division, the Company Jun 2018 Full-time Audit & Supervisory Board Member, the Company Jun 2023 Director, Full-time Audit and Supervisory Committee Member, the Company (current)

1956-04-24

Akira MITO

Director, Audit and Supervisory Committee Member

Jul 2013 Retired as Director of Okayama Nishi Tax Office Aug 2013 Opened Mito Tax Accountant Office (current) Jun 2015 Substitute Audit & Supervisory Board Member, the Company Jun 2016 Audit & Supervisory Board Member, the Company Jun 2023 Director, Audit and Supervisory Committee Member, the Company (current)

1953-01-07

Yoshiharu SAGAMI

Director, Audit and Supervisory Committee Member

Apr 1981 Joined Asahi Accounting Firm (currently Azusa Audit LLC) Jun 2010 Left the firm Jul 2010 Opened Sagami Certified Public Accountant Office (current) Jun 2015 Outside Director, Audit and Supervisory Committee Member, BR Holdings Co., Ltd. (current) Jun 2020 Audit & Supervisory Board Member, the Company Jun 2023 Director, Audit and Supervisory Committee Member, the Company (current)

1949-02-02

Large Shareholding Reports

No filings

Disclosures

No disclosures

Primary Source Filings

TDnet

2026-08-07

Q1 Earnings Flash

FY ending Mar 2027

JMS CO.,LTD.

Try the full product

JMS CO.,LTD.

Try the full product

More Japanese companies in Precision Instruments